Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
13.82
+0.02 (0.14%)
At close: Mar 28, 2025, 4:00 PM
13.83
+0.01 (0.07%)
After-hours: Mar 28, 2025, 4:50 PM EDT
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 609 employees as of September 30, 2024. The number of employees increased by 84 or 16.00% compared to the previous year.
Employees
609
Change (1Y)
84
Growth (1Y)
16.00%
Revenue / Employee
$4,105
Profits / Employee
-$1,050,433
Market Cap
1.74B
Employees Chart
ARWR News
- 6 days ago - Arrowhead Pharmaceuticals Is Finally Arriving - Seeking Alpha
- 18 days ago - Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy - Business Wire
- 22 days ago - Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases - Business Wire
- 4 weeks ago - Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS) - Business Wire
- 4 weeks ago - Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity - Business Wire
- 5 weeks ago - Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions - Seeking Alpha
- 5 weeks ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 6 weeks ago - Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript - Seeking Alpha